H. Verder et al., SURFACTANT THERAPY AND NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE FOR NEWBORNS WITH RESPIRATORY-DISTRESS SYNDROME, The New England journal of medicine, 331(16), 1994, pp. 1051-1055
Background. In southern Scandinavia most babies with respiratory distr
ess syndrome are initially treated with nasal continuous positive airw
ay pressure. We performed a multicenter trial to investigate whether t
he addition of a single dose of porcine surfactant administered during
a short intubation before the occurrence of serious deterioration cou
ld reduce the subsequent need for mechanical ventilation. Methods. We
randomly assigned 35 infants with moderate-to-severe respiratory distr
ess syndrome to surfactant therapy (Curosurf, 200 mg per kilogram of b
ody weight) plus nasal continuous positive airway pressure and 33 infa
nts to nasal continuous positive airway pressure alone. The study was
not blinded. The indications for mechanical ventilation were a ratio o
f arterial to alveolar oxygen tension of less than 0.15, severe apneic
attacks, or both. Results. Six hours after randomization, when the me
dian age of the babies was 18 hours, the mean ratio of arterial to alv
eolar oxygen tension was 0.37 in the surfactant-treated babies, as com
pared with 0.25 in the controls (P<0.001). The need for subsequent mec
hanical ventilation was reduced with surfactant therapy (to 43 percent
of the surfactant-treated babies, as compared with 85 percent of the
controls; P = 0.003). When 17 infants with ratios of arterial-to-alveo
lar oxygen tension of less than 0.15 at randomization were excluded, t
he need for mechanical ventilation was still significantly reduced in
the surfactant-treated group (to 33 percent [9 of 27 babies], as compa
red with 83 percent [20 of 24 babies] in the control group; P<0.001).
After 28 days, two of the surfactant-treated babies had died, as compa
red with five of the control babies. Conclusions. In babies with moder
ate-to-severe respiratory distress syndrome treated with nasal continu
ous positive airway pressure, a single dose of surfactant reduced the
need for subsequent mechanical ventilation.